ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 78

Ultraviolet Light Induces Increased T Cell Activation in Lupus-Prone Mice via Type I Interferon-Dependent Inhibition of T Regulatory Cells

Sonya Wolf-Fortune 1, Shannon Estadt 1, Jonathan Theros 1, Tyson Moore 1, Jason Ellis 1, Jianhua Liu 1, Tamra Reed 1, Chaim Jacob 1, Johann Gudjonsson 1 and J Michelle Kahlenberg1, 1University of Michigan, Ann Arbor, MI

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: interferons, Lupus, T cells and t reg

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: SLE – Animal Models Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Ultraviolet (UV) light is a known trigger of skin and possibly systemic inflammation in systemic lupus erythematosus (SLE) patients. Although type I interferons (IFN) are upregulated in SLE skin after UV exposure, the mechanisms to explain increased UVB-induced inflammation remain unclear. Here, we identified the role of type I IFNs in regulating immune cell activation between wild-type and lupus-prone mice following UVB exposure.

Methods: 10-week old female lupus-prone (NZM2328), wild-type (BALB/c) and iNZM mice (which lack a functional type I IFN receptor on NZM2328 background) were treated on their dorsal skin with 100mJ/cm2 of UVB for 5 consecutive days. Following UVB treatment, draining lymph node cell populations were characterized via flow cytometry and suppression assays. Treated skin was examined for changes in expression of type I IFN genes by real-time PCR.

Results: Two weeks following UVB exposure, lupus-prone NZM2328 mice showed an increase in draining lymph node size and expansion of T cell numbers and T cell activation in the draining lymph nodes. B cells were not increased. Neither Balb/c nor iNZM mice demonstrated this change. This T cell activation was preceded by a significant increase in UVB-induced type I IFN expression in the skin of NZM2328 mice compared to BALB/c mice. To explain the rise in T cell activation, T regulatory (Treg) cells were examined. Following UVB exposure, both BALB/c and iNZM mice demonstrated an increase in activated TReg cells in the draining lymph node 24 hours after the fifth UVB treatment; however, this was not seen in NZM2328 mice. In addition, Tregs isolated from NZM2328 mice draining lymph nodes were not functional in a T cell suppression assay. and this was dependent on type I IFNs as Tregs from UVB-treated iNZM demonstrated excellent suppressive capacity, similar to Balb/c mice.

Conclusion: These data suggest that an environment rich in type I IFNs, such as seen in lupus skin, promotes a skewed UVB-mediated T cell response in which activation of T cells is enhanced secondary to a type I IFN-dependent suppression of TReg cells. Thus, we propose that type I IFNs promote are important for UVB-induced inflammation and may be an effective target for prevention of UVB-mediated flares.


Disclosure: S. Wolf-Fortune, None; S. Estadt, None; J. Theros, None; T. Moore, None; J. Ellis, None; J. Liu, None; T. Reed, None; C. Jacob, None; J. Gudjonsson, AbbVie, 2, Genentech, 2, genentech, 2, MiRagen, 5, Novartis, 5, Sun Pharma, 2, SunPharma, 2; J. Kahlenberg, AstraZeneca, 5, Bristol Myers Squibb, 5, Eli Lilly, 5.

To cite this abstract in AMA style:

Wolf-Fortune S, Estadt S, Theros J, Moore T, Ellis J, Liu J, Reed T, Jacob C, Gudjonsson J, Kahlenberg J. Ultraviolet Light Induces Increased T Cell Activation in Lupus-Prone Mice via Type I Interferon-Dependent Inhibition of T Regulatory Cells [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/ultraviolet-light-induces-increased-t-cell-activation-in-lupus-prone-mice-via-type-i-interferon-dependent-inhibition-of-t-regulatory-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultraviolet-light-induces-increased-t-cell-activation-in-lupus-prone-mice-via-type-i-interferon-dependent-inhibition-of-t-regulatory-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology